Lunate Capital Ltd

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 20, 2025), Lunate Capital Ltd reported 5 stock positions worth $220.6 million. Its top holding was Revolution Medicines (RVMD) at 46.5% of the portfolio, followed by Sailpoint (SAIL, 30.0%) and Figure Technology Solut Class A (FIGR, 11.2%). Compared with Q2 2025, it opened 1 new position and sold out of 1. The biggest buy was a new position in Figure Technology Solut Class A (FIGR) and the biggest sale an exit from Samsara Class A (IOT).

Most Recent 13F
Q2 2026
Location
AL MARYAH ISLAND, ABU DHABI, C0
CIK
0002056786
Portfolio Value
$220.6M (Q3 2025)
SEC Filing
0001011438-25-000579 ↗ filed Nov 20, 2025

Holdings Value

0$100.0M$200.0M$300.0M Q1 2025: $171.2M Q1 2025 Q2 2025: $178.0M Q2 2025 Q3 2025: $220.6M $220.6M Q3 2025 Q4 2025: $263.8M Q4 2025 Q1 2026: $119.6M Q1 2026 Q2 2026: $196.0M Q2 2026

Holdings 5 stocks · $220.6M
RVMD Revolution Medicines Inc. 46.50% 2,196,200 $102.6M No change
SAIL Sailpoint Inc. 30.03% 3,000,000 $66.2M No change
FIGR Figure Technology Solut Class A 11.21% 680,000 $24.7M New
LINE Lineage Inc. 10.51% 600,000 $23.2M No change
NMRA Neumora Therapeutics Inc. 1.75% 2,124,143 $3.9M No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $135K (not counted above)
SecurityClassShares / PrincipalValueChange
RVMDW Revolution Medicines Inc.-28 *W EXP 12/17/202 450,000$135KNo change

Total filed on the 13F, all lines: $220.7M.

Portfolio Sells Q2 2025 → Q3 2025
IOT Samsara Inc. Class A Sold out 0.00% −0.51

Portfolio Buys Q2 2025 → Q3 2025
FIGR Figure Technology Solut Class A New 11.21% +11.21

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 10$196.0MSAIL, BIRK, LINE, BXSL, GSBD
Q1 2026 5$119.6MRVMD, SAIL, LINE, NMRA, NAVN
Q4 2025 5$263.8MRVMD, SAIL, LINE, NMRA, NAVN
Q3 2025Amended 5$220.6MRVMD, SAIL, FIGR, LINE, NMRA
Q2 2025 5$178.0MRVMD, SAIL, LINE, NMRA, IOT
Q1 2025 4$171.2MRVMD, SAIL, LINE, NMRA